Skip to main content
logo
VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6300
+0.0054 (0.86%)
At close: Mar 20, 2026, 4:00 PM EDT
0.6219
-0.0081 (-1.29%)
After-hours: Mar 20, 2026, 7:50 PM EDT

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $169.00K in the quarter ending September 30, 2025, with 39.67% growth. This brings the company's revenue in the last twelve months to $524.00K, up 6.29% year-over-year. In the year 2024, VYNE Therapeutics had annual revenue of $501.00K with 18.16% growth.

Revenue (ttm)
$524.00K
Revenue Growth
+6.29%
P/S Ratio
36.52
Revenue / Employee
$57,000
Employees
10
Market Cap
20.82M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024501.00K77.00K18.16%
Dec 31, 2023424.00K-53.00K-11.11%
Dec 31, 2022477.00K-454.00K-48.76%
Dec 31, 2021931.00K-20.06M-95.57%
Dec 31, 202020.99M20.55M4,638.83%
Dec 31, 2019443.00K-3.15M-87.68%
Dec 31, 20183.60M-987.00K-21.54%
Dec 31, 20174.58M3.91M579.82%
Dec 31, 2016674.00K--
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

VYNE News

More News